Company ProfilePremium

Ming Fai International Holdings Limited

Company Profile Analysis

Ticker: 3828.HK

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ming Fai International Holdings Limited - Company showcase

Year Founded & Workforce

1986

7,800 Employees

Ming Fai International Holdings Limited logo

Ming Fai International Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ming Fai International Holdings Limited Overview

Ming Fai International Holdings is a Hong Kong-headquartered, Cayman-incorporated, family-controlled manufacturer and distributor of guest amenities and operating supplies for the global hospitality and airline industries, with a smaller health-care and hygienic products contract-manufacturing arm serving North American customers. Founded by Chairman Ching Chi Fai, it describes itself as the first hotel-amenities supplier from the PRC region to list in Hong Kong (2007). The group generated HK$2,238.7 million of revenue in FY2025, 84% of it from hospitality supplies, sold across mainland China, Hong Kong, North America, Europe, Australia and other Asia-Pacific markets. Manufacturing is anchored in Shenzhen and a 130,240 m² Cambodian plant that is increasingly central to tariff-driven supply-chain repositioning. The company runs a net-cash balance sheet, pays out roughly half of earnings, and trades at a deep discount to book value — but faces sustained gross-margin compression from manufacturing costs, competition and trade-policy volatility.


Company's own description (paraphrased from AR25 and IR26)

AR25's Directors' Report states that the Company is an investment holding company whose subsidiaries are principally engaged in three activities: (i) manufacturing and trading of hospitality supplies products ("Hospitality Supplies Business"); (ii) trading of operating supplies and equipment ("OS&E Business"); and (iii) manufacturing and trading of health care and hygienic products ("Health Care and Hygienic Products Business"). The group's stated corporate aim (AR25, IR26) is to become a leading international corporate brand specialising in hospitality supplies and personal care products, create value for stakeholders, and support ecological sustainability.

The company's current web positioning emphasises four decades of experience, serving more than 100 million hotel and airline guests a year in-room and in-flight, and a product range spanning hotel supplies and equipment, airline and hospitality amenities, and personal-care products (WEB, accessed Oct 2026).

Independent characterisation

Revenue typeDescriptionApproximate weight (FY2025)Basis
Manufactured productsHotel/airline amenities (wet and dry), health-care & hygienic products~90% (Hospitality Supplies 84.0% + Health Care 5.8%)AR25 segment split; note Hospitality Supplies also includes some traded goods
Traded productsOS&E (linens, ceramics, kitchenware, lobby/cleaning supplies, outdoor furniture)~10% (OS&E 10.2%)AR25
Services / subscriptionNone reported0%AR25
LicensingGroup acts as licensee/distributor of third-party brands (e.g., Lanvin hotel amenities rights in Asia Pacific from 2012); no licensing income reported—WEB
Property rentalRental income from investment propertiesHK$1.9M in H1 2026 (in other income)IR26

Ming Fai is best understood as a B2B private-label and licensed-brand contract manufacturer of consumable guest amenities, overlaid with a trading/distribution business in hotel operating supplies. The economics are those of a mid-margin light-manufacturing exporter: gross margins in the low-to-mid 20s, operating margins of 5–8% in normal years, heavy labour content (employee benefit expense of HK$549.1 million in FY2025, equal to ~24.5% of revenue — AR25), and working capital intensity driven by long receivable cycles (credit terms of 15–120 days; ~105 days DSO in FY2025, derived).

Revenue model mix (as inferred from segment disclosures; the company does not report a product/service/licensing split):

Value-chain position: Ming Fai is vertically integrated from mould development, extrusion blow-moulding of bottles, paper printing and soft-goods sewing through to filling, packaging and logistics (WEB). In OS&E it is a sourcing and project-supply intermediary for new-build and refurbishing hotels, principally in mainland China.

Customer types (AR25 risk section): direct sales to hotels and airline operators, sales to distributors, and sales to other end-users. Customer concentration is moderate: the five largest customers accounted for less than 30% of FY2025 revenue, and the five largest suppliers for less than 30% of purchases (AR25).

End-markets served:

  • International hotel chains and independent hotels (in-room amenities, OS&E for openings)

  • Airlines (in-flight amenity kits and toiletries)

  • Cruise lines (the operating subsidiary appears in cruise-industry supplier directories)

  • North American health-care/hygiene brand owners (contract manufacturing; 95.5% of the Health Care segment's FY2025 revenue came from North America — AR25)

Strategy

Stated strategic themes (paraphrased from AR25 Outlook and IR26 Outlook)

AR25 and IR26 organise strategy around five recurring themes:

  1. Navigating global tourism under uncertainty. Maintain a prudent, pragmatic operating stance; strengthen internal governance; optimise resource allocation; improve product and service quality; and adjust business layout and product mix to capture niche opportunities, including a possible shift in travel demand toward closer destinations (IR26 cites UN Tourism's view that the Middle East conflict could cut 2026 international arrival growth by 1–2 points from an initial 3–4% forecast).

  2. Deepening Cambodian capacity to capture Southeast Asian opportunities. Use the Cambodian factory as a core operational base for capacity synergy, cost management and supply-chain resilience; leverage labour-cost advantages, regional tariff concessions and logistics connectivity; further review and optimise the footprint in Cambodia and surrounding regions (AR25 Chairman's statement and Outlook; IR26).

  3. Sustainability commitment. Embed ESG into strategy and operations; develop eco-friendly products, adopt energy-saving and carbon-reduction policies, source lower-impact raw materials (AR25; IR26).

  4. Enduring client relationships through product and service quality. End-to-end supply-chain quality control; deeper collaboration with existing clients; expansion into emerging markets and new customers (AR25; IR26).

  5. Prudent operations, capacity management and R&D optimisation. Increased focus on product development and technological upgrades; accelerate introduction of market-relevant products; flexible cross-regional capacity deployment (AR25; IR26).

For OS&E specifically, AR25 adds a goal of capturing Southeast Asian hotel-development activity and expanding strategic partnerships.

Initiatives in the last 24 months

InitiativePeriodDescriptionQuantified target
Cambodia production reallocation2025–2026Customer-requested transfer of Health Care production from PRC to Cambodia; allocation of Hospitality orders to CambodiaNone disclosed
VIE structure renewal22 May 2024New Shareholders' Agreement and Power of Attorney make the Cambodian land-holding arrangement indefinite—
Product portfolio adjustment in OS&E2025–2026Ongoing portfolio and quality-system optimisationNone disclosed
Eco-friendly product R&D2025–2026Development of ESG-compliant products and circular-economy practicesNone disclosed
KPI assessment and annual commendation award schemesOngoingEmployee performance programmesNone disclosed

Medium-term financial targets / guidance: Not publicly disclosed. The company provides no quantitative revenue, margin or earnings guidance; communication is limited to qualitative outlook language and Rule 13.09 profit warnings/alerts. The only quasi-policy target is the dividend policy, which has produced a payout ratio of ~50% for FY2023–FY2025 (AR24; AR25).

Products & Services

Hospitality Supplies Business

Product lineDescription / capabilitiesTarget customerLaunch / latest yearPricing modelSource
Wet amenitiesShampoo, conditioner, shower gel, body lotion and similar liquid toiletries; in-house formulation and filling; blow-moulded bottles produced in-houseHotels, resorts, airlines, cruise linesOngoing; launch year not disclosedNot publicly disclosed (B2B contract / private label)Vietnam Expo profile; WEB
Dry amenities and accessoriesGuest-room accessories such as compact mirrors, bath items, umbrellas and similar consumablesHotels——Morningstar business description
Acrylic hotel supplies and bath matsAcrylic room accessories; bath matsHotels——Morningstar business description
Airline amenity kitsIn-flight amenity kits and toiletries; sewing of handbags/pouches is an in-house capabilityAirlines——WEB (production capabilities); AR25 (airline operators named as customers)
Private-label programmesCustomised formulations and packaging for hotel chains' own brandsHotel chains——WEB; Malaysian JV profile
Licensed / distributed brandsLanvin (Asia-Pacific rights from 2012), STORM (from Mar 2013), Aquascutum, Pasion, CULTI collectionsUpscale and luxury hotels2012–2013 era; current status of each licence not publicly disclosed—WEB; Hotel Management Network profile
In-house luxury bath brandsEssence d'Orient; Rose Hotel CollectionUpscale hotelsc. 2013; current status not disclosed—Hotel Management Network profile
Sustainable / eco amenity rangesProducts designed with eco-friendly materials and ESG standards (e.g., reduced plastics, bulk formats); company also states support for abolition of animal testingHotels with sustainability programmesOngoing (2025–2026 emphasis)—AR25; WEB

OS&E Business (trading)

Product lineContentsTarget customerSource
Lobby suppliesSignage, luggage carts, ashtray pillars, railing stands, trash bins, floor matsHotel openings and refurbishmentsSimply Wall St business description
Cleaning suppliesCleaning equipment, tools and agentsHotelsSimply Wall St
Outdoor furnitureLeisure chairs, loungers, hammocks, swings, sun umbrellasResortsSimply Wall St
Linens and beddingTowels, bathrobes, tablecloths, bed sheets, blankets, pillows, work shoes and accessoriesHotelsSimply Wall St
Ceramic solutionsPorcelain sets, teacups, coffee utensils, glazed ceramics, Japanese and Korean ceramics, clay/stone pots, earthenwareHotel F&BSimply Wall St
Catering solutionsBuffet stoves and table-arrangement solutions, catering consumables, bakery suppliesHotel F&B and banquetingSimply Wall St
KitchenwareCutlery, pots, Chinese kitchen cookware and utensilsHotel kitchensSimply Wall St

Health Care and Hygienic Products Business

Product lineDescriptionTarget customerSource
Health-care and hygienic productsPersonal hygiene and health-care consumables (specific SKUs not disclosed)North American brand owners/retail customersAR25; IR26
Disposable infection-control productsSingle-use infection-control itemsNorth American and Hong Kong customersAR25; IR26

Flagship offerings (named): Lanvin-licensed hotel amenities (Asia Pacific), Essence d'Orient, Rose Hotel Collection, Aquascutum hotel toiletries. The extent to which each remains active in 2026 is not publicly disclosed.

Financial Narrative

Income statement

Sources: AR25 five-year summary and MD&A (revenue, PBT, tax, profit, attributable profit, EPS, DPS, gross profit FY2024–25, operating profit FY2024–25); FY22R (gross profit and operating profit FY2021–22); TR (operating profit FY2023); SA (D&A). EBITDA is derived as company-reported operating profit plus depreciation and amortisation.

Revenue CAGR FY2021–FY2025: 11.7% (derived: (2,238.7/1,435.8)^(1/4) – 1).

Commentary on trends and drivers.

FY2021 trough: Revenue was depressed by the pandemic-era collapse in travel; gross margin fell to 18.8% and the company booked an operating loss with a HK$48.0M loss on sale of investments recognised in the cash-flow reconciliation (SA), producing a HK$93.5M attributable loss.

FY2022–FY2024 recovery: Management's own profit alerts attribute the recovery to the reopening of Western and Southeast Asian borders driving hospitality demand, a COVID-related spike in hygiene demand in Hong Kong in Q1 2022, and cost-control and high-margin-mix measures (FY2022 profit alert; PPA23). Revenue compounded at ~17% from FY2021 to FY2024, gross margin rose 6.3 percentage points to 25.1%, and attributable profit reached a decade-plus high of HK$143.2M.

FY2025 inflection: Revenue declined 3.1% and gross margin fell 3.5 points to 21.6%, cutting attributable profit by 29.7%. The decline was driven by Hospitality Supplies margin compression and the tariff-driven disruption in Health Care (AR25; 9M-25). Quarterly cadence shows the deterioration was progressive: Q1 2025 gross margin 23.9% (Q1-25), H1 22.7% (H1-25), 9M 22.3% (9M-25), full-year 21.6%.

FY2023 tax anomaly: The 33.6% effective tax rate in FY2023 (vs ~21–22% otherwise) depressed net profit conversion; the cause is not explained in the sources reviewed.

Half-year income statement (latest)

Source: IR26.

Analyst observation. The HK$19.8M decline in H1 2026 operating profit is almost fully explained by a HK$21.0M swing in foreign-exchange results (a HK$15.2M gain in H1 2025 turning into a HK$5.8M loss in H1 2026, booked within administrative expenses — IR26 Note 4) plus a HK$5.3M swing in receivable impairments. Underlying gross profit fell HK$12.7M, while distribution costs rose HK$5.3M on higher volumes. This means the headline 31.8% profit decline overstates the operating deterioration somewhat — but the gross-margin trend itself (19.1%, the lowest since FY2021) is the genuine concern. Note also that IR26 states the group has no foreign-currency hedging policy, so FX noise will persist.

Balance sheet

Sources: AR25 five-year summary (total assets, equity, liabilities); SA (component detail).

Bank and other borrowings (company definition, excluding leases and NCI loans): HK$26.1M at 31 Dec 2024; HK$11.6M at 31 Dec 2025; HK$6.3M at 30 Jun 2026. Undrawn banking facilities: HK$440.4M (31 Dec 2025) and HK$445.6M (30 Jun 2026). Gearing ratio "not applicable" (net cash) at every recent balance-sheet date (AR25; IR26).

30 June 2026 snapshot (IR26): total assets HK$1,983.9M; cash HK$345.5M (of which HK$113.2M held in PRC banks subject to exchange controls); pledged deposit HK$11.8M; trade and bills receivables HK$658.2M net (gross HK$750.1M less HK$91.9M provision); inventories HK$303.8M; equity attributable HK$1,414.9M; total equity HK$1,353.1M; total liabilities HK$630.7M.

Commentary. The balance sheet is conservatively financed and has de-levered steadily: total debt fell from HK$164.6M (FY2021) to HK$39.6M (FY2025), and net cash quadrupled. Two items warrant monitoring. First, receivables quality: the impairment provision equals 12.3% of gross receivables at 30 Jun 2026, and HK$99.2M (13.2%) is aged over 180 days, up from HK$90.4M at end-2025 (IR26 Note 8). Second, the persistent negative non-controlling interest (–HK$61.8M at 30 Jun 2026) indicates accumulated losses in non-wholly-owned subsidiaries, alongside HK$17.3M of loans from non-controlling interests; the specific subsidiaries are not identified in the sources reviewed.

Cash flow

Source: SA (S&P Global), cross-checked to TR for FY2021–FY2024.

Note: TR reports FY2022 FCF of HK$104.7M and FY2023 of HK$168.0M versus SA's HK$105.6M and HK$171.1M — minor definitional differences.

H1 2026 / TTM: SA reports trailing-twelve-month (to 30 Jun 2026) operating cash flow of only HK$18.8M and FCF of –HK$22.6M, implying a weak H1 2026 cash performance (consistent with cash falling HK$72.9M in the half to HK$345.5M despite only HK$29.4M in dividends — IR26).

Commentary. Cash generation is volatile and driven by working-capital swings — receivables absorbed HK$138.8M in FY2024 but released HK$109.6M in FY2025 (SA). Over FY2022–FY2025 the group generated cumulative FCF of ~HK$487M against cumulative dividends of ~HK$174M and debt reduction of ~HK$152M, funding the build of net cash. Capex is modest (1–3.5% of revenue); FY2024 capex (HK$77.8M) was the five-year peak.

Key ratios

Ratios are derived by this analyst from the tables above unless otherwise noted. ROE and ROA use year-end balances. ROIC = operating profit × (1 – effective tax rate) ÷ (total equity + total debt – cash). Interest coverage = operating profit ÷ cash interest paid (SA). CCC components use year-end balances and cost of sales = revenue – gross profit.

Notes: FY2021 net debt/EBITDA is mathematically positive only because both net cash and EBITDA were negative/positive in opposite directions — it is not meaningful. SA's own FY2025 ratios: ROE 7.65%, ROA 3.68%, ROIC 9.94% (different denominators). TR's interest coverage for FY2024 (182x) differs from the derived 60x due to definitional differences in finance cost. Payout ratios for FY2023–FY2025 are company-reported (AR24, AR25); FY2022 is derived (4.0/10.4).

Ratio commentary. Returns peaked in FY2024 (ROE 10.8%, derived ROIC 13.9%) and have since retreated toward high-single digits; on a TTM basis to June 2026 attributable profit of ~HK$84.5M (SA) implies ROE closer to 6%. Working-capital efficiency has improved structurally — the cash conversion cycle shortened by ~53 days from FY2021 to FY2025, driven by both lower DSO and leaner inventory. Liquidity is ample (current ratio 2.2x; net cash ~29% of total equity at end-2025).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsKey geographies

Hospitality Supplies Business

Manufacture and trading of hotel and airline guest amenities (wet amenities such as shampoo, shower gel, conditioner, body lotion; dry amenities and accessories; amenity kits)

PRC, Hong Kong, North America, Europe, Other Asia Pacific (Macau, Singapore, Japan, UAE, Philippines), Australia, Africa (Kenya, Morocco, Tanzania)

OS&E Business

Trading of hotel operating supplies and equipment: lobby supplies, cleaning supplies, outdoor furniture, linens and bedding, ceramics, catering solutions, kitchenware

PRC (71–77%), other (Hong Kong, Macau, US)

Health Care and Hygienic Products Business

Manufacture and supply of health-care and hygienic products and disposable infection-control products

North America (95–97%), Hong Kong, others

Revenue by Segment

Segment metricFY2021FY2022FY2023FY2024FY2025

Hospitality Supplies revenue (HKD Mn)

1,095.31,381.51,699.81,933.21,883.7

OS&E revenue (HKD Mn)

156.4149.5193.3210.4228.5

Health Care and Hygienic revenue (HKD Mn)

191.5266.8176.9171.0128.9

Inter-segment elimination (HKD Mn)

-7.4-4.7-2.7-3.3-2.3

Group revenue (HKD Mn)

1,435.81,793.02,067.32,311.32,238.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment growth and mix (%)

Segment growth and mix (%)FY2021FY2022FY2023FY2024FY2025

Hospitality Supplies YoY growth (%)

—26.123.013.7-2.6

OS&E YoY growth (%)

—-4.429.38.88.6

Health Care YoY growth (%)

—39.4-33.7-3.4-24.6

Hospitality Supplies share of revenue (%)

76.377.082.283.684.1

OS&E share of revenue (%)

10.98.39.49.110.2

Health Care share of revenue (%)

13.314.98.67.45.8

Segment gross profit

Segment gross profitFY2024FY2025

Hospitality Supplies gross profit (HKD Mn)

477.0391.4

OS&E gross profit (HKD Mn)

51.653.4

Health Care gross profit (HKD Mn)

51.339.9

Hospitality Supplies gross margin (%)

24.720.8

OS&E gross margin (%)

24.523.4

Health Care gross margin (%)

30.031.0

Results by Segment and Segment Margins & Growth (%)

Half-year segment metricH1 2025H1 2026

Hospitality Supplies revenue, external (HKD Mn)

877.6914.3

OS&E revenue, external (HKD Mn)

95.7137.5

Health Care revenue, external (HKD Mn)

55.3106.4

Hospitality Supplies gross profit (HKD Mn)

194.9158.1

OS&E gross profit (HKD Mn)

22.331.6

Health Care gross profit (HKD Mn)

16.631.4

Hospitality Supplies gross margin (%)

22.217.3

OS&E gross margin (%)

23.323.0

Health Care gross margin (%)

30.029.5

Hospitality Supplies segment PBT (HKD Mn)

48.617.5

OS&E segment PBT (HKD Mn)

5.79.0

Health Care segment PBT (HKD Mn)

7.215.6

Unallocated / others PBT (HKD Mn)

-0.6-0.7

Segment assets (HKD Mn)

Segment assets (HKD Mn)31 Dec 202530 Jun 2026

Hospitality Supplies total assets

2,008.21,999.0

of which Cambodia

396.5421.4

OS&E total assets

307.5304.7

Health Care total assets

69.395.3

Others

38.338.4

Inter-segment elimination

-419.3-453.5

Group total assets

2,004.01,983.9

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

1,435.81,793.02,067.32,311.32,238.7

Revenue growth (%)

6.124.915.311.8-3.1

Gross profit (HKD Mn)

269.6424.8501.7579.9484.7

Operating profit (HKD Mn)

-92.491.8144.1173.7120.7

Depreciation and amortisation (HKD Mn)

65.665.161.968.663.5

EBITDA, derived (HKD Mn)

-26.8156.9206.0242.3184.2

Profit before tax (HKD Mn)

-94.490.0144.1177.6125.2

Income tax expense (HKD Mn)

3.520.148.438.426.6

Profit for the year (HKD Mn)

-97.969.895.6139.198.6

Profit attributable to owners (HKD Mn)

-93.575.5104.2143.2100.7

Basic EPS (HK cents)

-12.810.414.419.813.9

Diluted EPS (HK cents)

-12.810.414.419.813.9

Dividend per share (HK cents)

04.07.010.07.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin metric (%)

Margin metric (%)FY2021FY2022FY2023FY2024FY2025

Gross margin (%)

18.823.724.325.121.6

Operating margin (%)

-6.45.17.07.55.4

EBITDA margin, derived (%)

-1.98.810.010.58.2

Net margin, attributable (%)

-6.54.25.06.24.5

Effective tax rate (%)

-3.722.433.621.621.2

Income Statement and Margin Analysis (%) (Half-Yearly)

Half-year metricH1 2025H1 2026

Revenue (HKD Mn)

1,028.61,158.2

Cost of sales (HKD Mn)

794.8937.1

Gross profit (HKD Mn)

233.8221.1

Gross margin (%)

22.719.1

Other income (HKD Mn)

3.64.5

Distribution costs (HKD Mn)

109.3114.7

Administrative expenses (HKD Mn)

69.767.1

Net impairment (losses)/reversals on financial assets (HKD Mn)

1.4-3.9

Operating profit (HKD Mn)

59.740.0

Net finance income (HKD Mn)

1.01.5

Profit before tax (HKD Mn)

61.342.0

Income tax (HKD Mn)

11.18.3

Profit attributable to owners (HKD Mn)

50.934.7

Basic EPS (HK cents)

7.04.8

Interim DPS (HK cents)

3.02.5

Net exchange (loss)/gain within expenses (HKD Mn)

15.2-5.8

Employee benefit expenses (HKD Mn)

263.0275.9

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

1,738.71,749.51,965.21,995.32,004.0

Current assets (HKD Mn)

1,144.71,204.31,406.91,441.31,456.7

Cash and cash equivalents (HKD Mn)

251.2305.4375.1328.6418.4

Trade and other receivables (HKD Mn)

557.4575.0622.7741.1673.5

Inventories (HKD Mn)

266.3260.2329.1307.9290.3

Property, plant and equipment incl. ROU (HKD Mn)

551.4507.1490.3490.4461.7

Goodwill and intangibles (HKD Mn)

5.85.95.75.75.9

Short-term debt incl. loans from NCI (HKD Mn)

156.0126.064.341.327.0

Long-term debt (HKD Mn)

2.72.22.21.81.6

Lease liabilities (HKD Mn)

5.99.08.33.011.0

Total debt incl. leases (HKD Mn)

164.6137.274.846.139.6

Net cash (HKD Mn)

88.1169.8302.0285.0380.3

Current liabilities (HKD Mn)

621.7596.4748.6714.1665.6

Total liabilities (HKD Mn)

644.3618.0772.0732.0690.1

Equity attributable to owners (HKD Mn)

1,141.01,181.01,251.01,323.01,375.1

Non-controlling interests (HKD Mn)

-46.2-49.7-57.5-60.0-61.2

Total equity (HKD Mn)

1,094.41,131.51,193.21,263.31,313.9

Working capital (HKD Mn)

523.0608.0658.3727.1791.1

Book value per share (HKD)

1.551.611.701.801.87

Cash Flow and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (HKD Mn)

-98.7129.8228.7113.1205.8

Change in working capital (HKD Mn)

-112.5-37.750.5-96.173.4

Capital expenditure (HKD Mn)

-44.3-24.2-57.6-77.8-30.4

Free cash flow (HKD Mn)

-143.0105.6171.135.3175.4

FCF margin (%)

-10.05.98.31.57.8

Dividends paid (HKD Mn)

-10.9-7.2-36.2-57.9-72.3

Share buybacks (HKD Mn)

0-2.2000

Net debt repaid (HKD Mn)

14.6-36.0-67.3-28.6-20.1

Cash income tax paid (HKD Mn)

33.1-4.038.845.653.6

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE, attributable (%)

-8.26.48.310.87.3

ROA (%)

-5.64.04.97.04.9

ROIC, derived (%)

-9.27.410.713.910.2

Current ratio (x)

1.842.021.882.022.19

Debt to equity (x)

0.150.120.060.040.03

Net debt to EBITDA (x, negative = net cash)

3.29-1.08-1.47-1.18-2.06

Interest coverage (x)

-38.019.523.160.191.4

Asset turnover (x)

0.831.021.051.161.12

Days sales outstanding

135.0114.4108.5115.6105.4

Days inventory outstanding

83.369.476.764.960.4

Days payables outstanding

55.844.965.955.656.0

Cash conversion cycle (days)

162.5138.9119.3124.9109.8

Dividend payout ratio (%)

038.548.650.550.4

Revenue by Region

Region (group revenue, HKD Mn)FY2021FY2022FY2023FY2024FY2025

Mainland China (Hospitality + OS&E)

635.5457.6691.1686.1635.1

Hong Kong (Hospitality + Health Care)

202.9254.1187.6296.5366.3

North America (Hospitality + Health Care)

264.8338.1413.3485.4401.0

Europe (Hospitality)

97.3251.0262.1315.9297.8

Other Asia Pacific (Hospitality)

144.5262.2357.0375.7365.9

Australia (Hospitality)

30.4151.091.490.1101.0

Other / unallocated

60.579.164.861.571.7

Total

1,435.81,793.02,067.32,311.32,238.7

Regional growth (YoY %)

Regional growth (YoY %)FY2023FY2024FY2025

Mainland China

51.0-0.7-7.4

Hong Kong

-26.258.023.5

North America

22.317.4-17.4

Europe

4.420.5-5.7

Other Asia Pacific

36.25.2-2.6

Australia

-39.5-1.412.1

Revenue by Region (FY2024–FY2025)

Hospitality Supplies region (HKD Mn)FY2024FY2025

PRC

528.0470.9

Hong Kong

294.4363.2

North America

323.0278.1

Europe

315.9297.8

Other Asia Pacific

375.7365.9

Australia

90.1101.0

Hospitality Supplies region share (%)

Hospitality Supplies region share (%)FY2024FY2025

PRC

27.325.0

Hong Kong

15.219.3

North America

16.714.8

Europe

16.415.8

Other Asia Pacific

19.519.4

Australia

4.75.4

Revenue by Region (Half-Yearly)

Hospitality Supplies region, half-year (HKD Mn)H1 2025H1 2026

PRC

208.0232.7

Hong Kong

138.4194.5

North America

158.2123.7

Europe

147.6134.2

Other Asia Pacific

172.5176.9

Australia

51.350.6

Revenue by Region by OS&E and Health Care Regions

OS&E and Health Care regions (HKD Mn)FY2024FY2025

OS&E — PRC

155.3162.7

OS&E — other markets

55.165.8

Health Care — North America

162.4122.9

Health Care — Hong Kong

1.82.3

Health Care — other markets

6.63.5

Revenue by Region (H1 2025–H1 2026)

OS&E and Health Care regions, half-year (HKD Mn)H1 2025H1 2026

OS&E — PRC

65.2105.7

OS&E — other markets

30.531.8

Health Care — North America

52.4102.8

Health Care — Hong Kong

1.01.7

Health Care — other markets

1.91.9

Capital Markets

ItemValueDate / basisSource

Share price

HK$0.725

9 Oct 2026

SA

Share price

HK$0.77

17 Jul 2026 and 31 Jul 2026

SA

52-week price change

-10.47%

to 17 Jul 2026

SA

50-day / 200-day moving average

HK$0.79 / HK$0.89

17 Jul 2026

SA

Beta (5Y)

0.45

Jul 2026

SA

Market capitalisation

≈HK$532M

9 Oct 2026, derived

derived

Enterprise value

≈HK$219M (market cap + HK$32.3M debt incl. leases/NCI loans – HK$345.5M cash at 30 Jun 2026)

derived

derived

P/E (TTM attributable profit HK$84.5M)

≈6.3x

derived

derived from SA

P/E (FY2025)

≈5.3x

derived

derived

EV/EBITDA (TTM, ≈HK$160M)

≈1.4x

derived

derived

EV/Sales (TTM revenue HK$2,368M)

≈0.09x

derived

derived

P/B (equity attributable HK$1,414.9M)

≈0.38x

30 Jun 2026, derived

derived

Dividend yield (TTM DPS HK$0.065)

≈9.0%

Oct 2026

SA

Average daily volume (20 days)

~201,600 shares

Jul 2026

SA

Altman Z-score / Piotroski F-score

2.81 / 6

Jul 2026

SA

Dividend metric

Dividend metricFY2021FY2022FY2023FY2024FY2025

Total DPS (HK cents)

04.07.010.07.0

Payout ratio (%)

038.548.650.550.4

Dividends paid in cash (HKD Mn)

10.97.236.257.972.3

Analyst Conclusions

Management guidance

No quantitative guidance. Management describes a cautiously optimistic stance (AR25 Chairman's statement), anchored on continuous innovation and sustainability as dual growth drivers, flexible capacity deployment in Cambodia, and prudent financial management (AR25; IR26). Consensus growth expectations: none available.

Bull case (grounded in data above)

  1. Margin trough plus volume recovery. H1 2026 revenue grew 12.6% with all three segments growing; if gross margin merely recovers to its FY2025 level of 21.6% from 19.1%, the improvement on a ~HK$2.3–2.4bn revenue base would be worth roughly HK$55–60M of gross profit annually — more than half of FY2025 attributable profit.

  2. Cambodia as a structural winner. Health Care revenue nearly doubled and segment PBT more than doubled in H1 2026 once Cambodian capacity ramped; US customers' diversification away from China supports further allocation to the plant.

  3. Extreme valuation cushion. At ≈0.38x book, ≈1.4x EV/EBITDA and a ~9% dividend yield, with net cash covering roughly 60% of market capitalisation, the market is pricing in sustained decline; the FX loss in H1 2026 (HK$5.8M) is non-recurring by nature.

Bear case

  1. Structural margin compression in the core. Hospitality gross margin has fallen from 24.7% (FY2024) to 17.3% (H1 2026); management attributes this to competition and costs, suggesting pricing power is weak and the decline may not be cyclical.

  2. Deteriorating cash conversion. TTM operating cash flow to June 2026 was only HK$18.8M and TTM FCF negative (SA); cash fell by HK$72.9M in H1 2026, and receivables over 180 days are rising.

  3. Governance and capital-allocation discount is likely to persist. A family-controlled board without a CEO, no buybacks since 2022 despite a deep discount to book, and an expired share-award scheme with no grants ever made give minority holders limited catalysts.

Key catalysts and monitorables (next 12 months)

MonitorableWhy it mattersTiming
Voluntary 9M 2026 business updateTests whether H2 margins stabilise; company issued 9M updates in Nov 2025~Nov 2026
FY2026 profit warning / alertRule 13.09 announcements have preceded each of the last two results~Mar 2027
FY2026 annual results and final dividendPayout policy and margin trajectory~late Mar 2027
Hospitality gross marginCore driver of earningsEach reporting period
Oil, resin and freight costsIR26 links margin pressure to oil pricesContinuous
US tariff decisions on PRC and Cambodian originsDrives Health Care and North America HospitalityContinuous
China hotel openings and pipelineOS&E demandQuarterly Lodging Econometrics data
Receivable ageing and impairmentsCredit qualityEach reporting period
Share-award scheme renewal or buyback activityCapital-allocation signalAGM ~May 2027
Webb holdings changes (16.33%)Potential shareholder activism or exitDisclosure-of-interest filings

Analyst verdict

Ming Fai International is a financially sound but operationally pressured small-cap manufacturer whose share price reflects a market that has largely stopped believing in its earnings power. The facts are stark in both directions. On one side, the group carries net cash of over HK$300 million, minimal borrowings, HK$445 million of undrawn facilities, and an equity base of HK$1.41 billion against a market capitalisation of roughly HK$530 million. It has paid out about half of its profits for three consecutive years, and its H1 2026 top line grew double-digits across every segment, with Cambodia emerging as a genuine strategic asset for tariff-sensitive North American customers.

On the other side, the core Hospitality Supplies franchise — 79–84% of revenue — is losing margin at an alarming pace: from 24.7% in FY2024 to 17.3% in H1 2026, collapsing segment profit by nearly two-thirds year-on-year. Management's explanations (cost inflation, competition, external volatility) are plausible but also imply weak pricing power. Cash generation weakened markedly in the first half of 2026, receivable ageing is drifting upward, and the absence of hedging leaves earnings exposed to RMB swings.

Governance offers little catalyst: a founder-controlled board with family representation, no CEO, no buybacks despite trading at under 0.4x book, and no disclosed medium-term targets. The 16.33% stake held by Webb-linked entities is the most interesting latent governance variable.

Our assessment is that the stock is statistically cheap and balance-sheet protected, but a re-rating requires evidence that Hospitality margins have bottomed — something the next 9M update and FY2026 results will test. Until then, the investment case is essentially a high-yield, asset-backed holding with meaningful dividend-cut risk (DPS has already fallen from 10.0 to 7.0 cents, and the interim from 3.0 to 2.5 cents). Verdict: value with a margin-recovery option; monitor, rather than chase.


All figures are from public company filings and named third-party data providers as cited. "Derived" figures are analyst calculations from disclosed data.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAge (AR25)Board tenurePrior roles / responsibilitiesEducation

CHING Chi Fai

Chairman, Executive Director; chairs Nomination, Executive and Investment Committees; member Remuneration Committee

64

Since 2007 (18 years)

Founder; responsible for sales & marketing, production and overall corporate direction; 30+ years in hospitality supplies

—

CHING Chi Keung

Executive Director; member Executive Committee

61

Since 2007

Joined with founders; human resources and administration; brother of Chairman

—

LIU Zigang

Executive Director; member Executive Committee

60

Since 2007

Joined May 1995; oversees Greater China sales

MBA, Centenary College of New Jersey (2011); diploma, Shenzhen University; Tsinghua University international business management course

CHING Tsun Wah

Executive Director; Business Development Director; member Executive Committee

44

Since 2014 (11 years)

Joined 2006 in production; oversees Southeast Asia and overseas sales; son of Chairman; Cambodian citizen; holds 51% of Cambodian land-holding company under VIE

Marketing administration, Seneca College, Toronto (2003)

KEUNG Kwok Hung

Executive Director; CFO; Company Secretary; member Executive and Investment Committees

53

Since 2014

Joined Jul 2010; 30+ years accounting/finance

BA Accountancy, Hong Kong Polytechnic University; FCPA (HKICPA), FCCA

CHAN Yim Ching

Non-Executive Director; member Nomination Committee

58

NED since 2015; ED 2007–2015

Joined 1995; export sales

—

HUNG Kam Hung Allan

Independent NED; chairs Remuneration Committee

71

Since 2007 (18 years)

Former deputy MD/ED of Top Glory International; hotel development consultant since 2005

—

SUN Eric Yung Tson

Independent NED

49

Since 2016 (9 years)

MD of Kin Hip Metal & Plastic Factory and KINOX Trading since 2006; president, HK Plastics Manufacturers Association; chairman, HK Exporters' Association

B.Com, University of New South Wales (2000)

KWONG Tony Wan Kit

Independent NED; chairs Audit Committee; member Investment Committee

48

Since 2021 (4 years)

CFO of Top Form International (HKEX-listed); former roles at Wise Ally, Defond, Valuetronics

MBA, Anglia Ruskin University; BBA Accountancy, City University of Hong Kong; FCPA, FCCA

“—” = not publicly disclosed.

Directors' Remuneration

AttributeDetail

Board size

9 (5 ED, 1 NED, 3 INED)

Independence

33% independent (3 of 9) — meets the Listing Rules minimum of one-third

Gender

1 female (11%); board target is to maintain at least one female director

Age profile

1 director aged 40–49... (AR25 chart: 1 in 40–49, 1 in 50–59, 7 aged 60 or above per board-diversity chart; note bios list two directors aged 48–49, so chart groupings appear to be by different cut-offs — discrepancy noted)

Chair/CEO

No CEO; Chairman is the founder and controlling shareholder

Family relationships

Chairman, his brother (ED) and his son (ED) all sit on the board

Audit Committee

Kwong (Chair), Hung, Sun — all INEDs

Remuneration Committee

Hung (Chair), Ching Chi Fai, Sun, Kwong

Nomination Committee

Ching Chi Fai (Chair), Chan Yim Ching, Hung, Sun, Kwong

Executive Committee

All five EDs, chaired by Ching Chi Fai

Investment Committee

Ching Chi Fai (Chair), Keung, Kwong

Terms

EDs: 3-year service contracts; NED/INEDs: 1-year letters of appointment; all subject to rotation

Major Shareholders

HolderShares% of issuedNature

CHING Chi Fai (incl. Prosper Well International 165,166,600; 30.77% attribution of Targetwise's 32,499,600; personal 23,690,000)

221,356,20030.15

Controlling shareholder (spouse LO Kit Ling deemed interested in same shares)

Prosper Well International Limited (wholly owned by Ching Chi Fai)

165,166,60022.49

Included above

David Michael WEBB and Karen Anne WEBB (jointly, via Preferable Situation Assets and Member One)

119,920,00016.33

Substantial shareholder

Preferable Situation Assets Limited

69,987,7009.53

Webb vehicle

Member One Limited

49,932,3006.80

Webb vehicle

CHING Chi Keung (incl. Targetwise Trading 32,499,600)

36,499,6004.97

Director

CHAN Yim Ching (via Targetwise Trading)

32,499,6004.43

Director (overlaps with Targetwise above)

LIU Zigang (incl. Favour Power 20,057,200)

24,057,2003.28

Director

CHING Tsun Wah (incl. spouse 775,000)

4,509,0000.61

Director

HUNG Kam Hung Allan

600,0000.08

INED

Competitive Landscape

Key Competitors

CompetitorSegment overlapHQOwnershipPositioning vs Ming Fai

ADA Cosmetics International

Hotel amenities (licensed luxury brands)

Germany

Private

Strong in European luxury licensed amenities; competes in Europe and Asia

Guest Supply

Hotel amenities and guest-room supplies

United States

Division of Sysco

Scale distributor in North America with procurement leverage

Gilchrist & Soames

Luxury hotel amenities

United States

Private

Upscale North American brand-led amenities

Marietta Corporation

Private-label hotel amenities manufacturing

United States

Private

North American contract manufacturer; direct rival in private label

Hunter Amenities

Hotel amenities

Canada

Private

North American amenities supplier

Mainland Chinese amenity manufacturers (Yangzhou/Guangdong clusters)

Hotel amenities, dry goods

PRC

Mostly private

Low-cost competition; primary source of the "intensified competition" management cites

Regional OS&E specialists in China and Southeast Asia

OS&E for hotel openings

PRC / SE Asia

Private

Project-based competition for hotel openings

Hotel chains' in-house/global procurement programmes

Amenities, OS&E

Global

Divisions of hotel groups

Monopsony buyers that can tender globally

Health-care OEM manufacturers in Southeast Asia (Vietnam, Malaysia, Thailand, Indonesia)

Health care and hygienic contract manufacturing

SE Asia

Mixed

Alternative "China+1" origins for US customers

PRC hygiene/disposable producers

Infection-control disposables

PRC

Mixed

Tariff-disadvantaged into US but price-competitive elsewhere

Competitor Detail

Benchmark metricMing Fai FY2025

Revenue

HK$2,238.7M

Revenue growth

-3.1%

Gross margin

21.6%

Operating margin

5.4%

Company Snapshot

$287.4M

Revenue

7,800

Employees

1986

Founded

Grand Cayman, Cayman Islands

Headquarters

SWOT Analysis

Strengths

  • Net-cash balance sheet: net cash of HK$380.3M at FY2025 (SA) and HK$313.2M at 30 Jun 2026; bank/other borrowings only HK$6.3M with HK$445.6M of undrawn facilities (IR26).
  • Cambodian manufacturing base: a 130,240 m² plant (WEB) whose Hospitality segment assets rose to HK$421.4M at 30 Jun 2026 (IR26), enabling tariff-advantaged supply to US customers.
  • Customer diversification: five largest customers <30% of FY2025 revenue; five largest suppliers <30% of purchases (AR25).
  • Geographic breadth: no single region above ~28% of group revenue in FY2025 (derived from SA).
  • Working-capital discipline: cash conversion cycle cut from 162.5 days (FY2021) to 109.8 days (FY2025) (derived).
  • Consistent shareholder returns: ~50% payout for three consecutive years (48.6%, 50.5%, 50.4% — AR24/AR25), yielding ~9% at recent prices (SA).

Weaknesses

  • Gross-margin erosion: group GM fell from 25.1% (FY2024) to 21.6% (FY2025) to 19.1% (H1 2026) (AR25; IR26).
  • Core-segment profitability collapse: Hospitality segment PBT fell from HK$48.6M to HK$17.5M in H1 2026 (IR26).
  • No FX hedging: RMB-heavy cost base; H1 FX swung from a HK$15.2M gain to a HK$5.8M loss (IR26).
  • Receivables quality: impairment provision of HK$91.9M (12.3% of gross receivables) and HK$99.2M aged >180 days at 30 Jun 2026 (IR26).
  • Governance concentration: no CEO; three family members on the board; two INEDs with 9+ years' tenure (AR25).
  • Opacity: no disclosure of R&D spend, product-line revenue or quantitative guidance (AR25; IR26).

Opportunities

  • China hotel pipeline: ~640,000 rooms under construction feeding OS&E demand (IR26); OS&E revenue +43.7% in H1 2026.
  • Health Care rebound via Cambodia: segment revenue +92.4% and PBT more than doubled to HK$15.6M in H1 2026 (IR26).
  • Southeast Asian hotel development: explicitly targeted for OS&E expansion (AR25).
  • Sustainable amenities: customer demand for eco-friendly products, which management is prioritising in R&D (AR25).
  • Asset monetisation: investment properties of HK$79.6M (30 Jun 2026) and a recent HK$15.1M revaluation gain point to latent property value (IR26).
  • Valuation re-rating potential: P/B ≈0.38x and EV/EBITDA ≈1.4x (derived) leave room for a re-rating if margins stabilise.

Threats

  • US trade policy: tariffs prompted forced relocation and a 24.3% fall in Health Care North America revenue in FY2025 (AR25).
  • Energy and logistics shocks: IR26 attributes higher raw-material and logistics costs to oil-price increases from the Middle East conflict.
  • Competitive intensity: management cites intensified competition as restricting pricing in both AR25 and IR26.
  • Travel slowdown: UN Tourism warned 2026 arrival growth could be cut by 1–2 points (IR26).
  • Cambodian legal risk: VIE land structure could be reinterpreted by Cambodian authorities; no insurance cover (AR25).
  • PRC capital controls: HK$113.2M of cash held in PRC banks subject to exchange controls (IR26).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
28 Feb 2025INED Ng Bo Kwong resigns AR25Board reduced to 3 INEDs
31 Mar 2025Disclosure of interests: Preferable Situation Assets 9.51% and Member One 6.78% (Webb vehicles) AR25Confirms significant minority investor
Apr 2025US announces new round of tariffs (referenced in Q1 update) Q1-25Triggers customer relocation requests for Health Care production
22 Apr 2025Annual Report 2024 published AR24FY2024 record year documented; DPS 10.0 cents; payout 50.5%
20 May 2025Q1 2025 voluntary update: revenue HK$505.1M (-4.8%), GP HK$120.5M (-9.9%), GM 23.9% Q1-25First sign of downturn; Hospitality revenue down on weaker travel demand
22 May 2025AGM passes all resolutions incl. FY2024 final dividend, director re-elections, buyback and issuance mandates TipRanksRoutine
31 May 2025Webb disclosure updated: holdings held jointly by David and Karen Webb; combined 16.33% AR25Ownership clarity
26 Aug 2025H1 2025 results: revenue HK$1,028.6M (+0.5%), attributable HK$50.9M (-4.4%), interim DPS 3.0 cents H1-25Margin pressure emerging
10 Sep 2025Interim Report 2025 published H1-25Routine
30 Sep 2025Interim dividend of HK3.0 cents paid (~HK$22.0M) AR25Shareholder return
12 Nov 20259M 2025 voluntary update: revenue HK$1,649.2M (-2.3%), GP HK$368.0M (-12.4%), GM 22.3%; cash HK$425.2M 9M-25Health Care disrupted by Cambodia relocation; Hospitality margin falling
Late Nov 2025Group issues statement of condolence after the Wang Fuk Court fire in Tai Po, Hong Kong WEBReputational/CSR communication
Mar 2026Profit warning: FY2025 attributable profit expected ≥HK$100M (vs HK$143.2M) due to lower gross margin from manufacturing costs PW25FYPre-announces earnings decline
26 Mar 2026FY2025 results: revenue HK$2,238.7M (-3.1%), attributable HK$100.7M (-29.7%), final DPS 4.0 cents (total 7.0) AR25Dividend cut 30%
Apr 2026Annual Report 2025 and ESG Report 2025 published AR25Governance disclosure
20 May 2026AGM approves FY2025 final dividend; re-election of Ching Chi Keung, Ching Tsun Wah and Hung Kam Hung Allan scheduled AR25; IR26Routine
22 May 2026Ex-dividend date for final dividend SARoutine
5 Jun 2026Final dividend paid (~HK$29.4M) AR25; IR26Shareholder return
13 Jun 2026Group participates in CTIDC 2026, Kunming WEBChina hotel-investment networking
H1 2026Property transferred from PP&E to investment property; HK$15.1M revaluation gain in OCI IR26Asset monetisation signal
11 Aug 2026Profit warning: H1 2026 attributable profit expected ≥HK$34.0M (vs HK$50.9M) PW26HMargin pressure intensifies
25 Aug 2026H1 2026 results: revenue HK$1,158.2M (+12.6%), GM 19.1%, attributable HK$34.7M (-31.8%), interim DPS 2.5 cents IR26Volume recovery but margin trough
18 Sep 2026Record date for interim dividend IR26Routine
23 Sep 2026Scheduled expiry of the 10-year Share Award Scheme (no renewal announcement identified) AR25Incentive-scheme gap
30 Sep 2026Interim dividend of HK2.5 cents paid (~HK$18.4M) IR26Shareholder return
2 Oct 2026Monthly return for September: 734,262,697 shares, no change; public float compliant FF301No dilution

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

10 charts
Income Statement: Revenue & Gross Profit (FY2021–FY2025): Revenue rose from HKD 1,435.8 Mn in FY2021 to HKD 2,238.7 Mn in FY2025.
Ming Fai International Holdings Limited — Income Statement: Revenue & Gross Profit (FY2021–FY2025)
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue1,435.81,7932,067.32,311.32,238.7
Gross profit269.6424.8501.7579.9484.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.